Federal Circuit / U.S. Court of Spec. Jurisdiction

Published between:
Published Title Organization
Nov
5
2019
 Federal Circuit Cans Prior Art Exclusion for “Ever-So-Slight” Design Differences McDermott Will & Emery
Nov
5
2019
 Federal Circuit Sides With PTO On Applicant Delay In Patent Term Adjustment McDermott Will & Emery
Nov
5
2019
 Basket Case: Article Name Limits Design Patent Claim McDermott Will & Emery
Nov
5
2019
 Patent Term Adjustment Denied For Interference-Related Delays McDermott Will & Emery
Nov
5
2019
 Evidence of Copying Must Be Considered In Obviousness Analysis Foley & Lardner LLP
Nov
4
2019
 Federal Circuit Rules That Appointment Of PTAB Judges Violates The Constitution Barnes & Thornburg LLP
Nov
4
2019
 Federal Circuit Rules that PTAB Judges are Unconstitutionally Appointed Schwegman, Lundberg & Woessner, P.A.
Nov
4
2019
 Federal Circuit Holds Appointment of PTAB Judges Violates the Constitution, Vacates and Remands Final Written Decision Mintz
Nov
3
2019
 Unconstitutionality of PTAB Judges Corrected by Federal Circuit Decision K&L Gates LLP
Nov
1
2019
 Federal Circuit Says PTAB APJ Appointments Were Unconstitutional – Now What? Womble Bond Dickinson (US) LLP
Nov
1
2019
 Federal Circuit Demotes Unconstitutionally Appointed PTAB Judges Foley & Lardner LLP
Nov
1
2019
 Federal Circuit Uses Judicial Power To Sever Unconstitutional Provision Of Patent Statute To Keep USPTO Inter Partes Review Procedure Intact Brinks Gilson & Lione
Oct
28
2019
 Walking the Jurisdictional Line: Cashing in on Federal Jurisdiction in Patent Licensing Disputes Womble Bond Dickinson (US) LLP
Oct
16
2019
 Personalized Cancer Therapy Found Nonobvious Foley & Lardner LLP
Oct
15
2019
 Federal Circuit Reverses PTAB Finding Tarceva® Method of Treatment Claims Invalid for Lack of Reasonable Expectation of Success Based on over 99.5% Failure Rate among Treatment Candidates Mintz
Oct
15
2019
 Federal Circuit Reverses PTAB On Reasonable Expectation Of Success For TARCEVA Patent Foley & Lardner LLP
Oct
11
2019
 OSI v. Apotex – Christmas in October! Schwegman, Lundberg & Woessner, P.A.
Oct
11
2019
 PTAB Precedential Decision on 35 U.S.C. § 315(a)(1) Shows Dismissed Civil Actions Still Bar IPR Institution Foley & Lardner LLP
Oct
11
2019
 Lack of Co-ownership for Terminally Disclaimed Patents May Doom a Lawsuit and Result in an Award of Attorneys’ Fees Faegre Drinker
Oct
10
2019
 Collateral Estoppel Does Not Attach To PTAB Invalidity Determination Pending Appeal Mintz
Oct
9
2019
 A Win is a Win! K&L Gates LLP
Oct
9
2019
 Don’t B Late; Federal Circuit Interprets The B Delay Calculation K&L Gates LLP
Oct
8
2019
 USPTO to Tweak PTA Rules in View of Supernus Foley & Lardner LLP
Oct
7
2019
 Today’s Special: Validity Goulash – Serving Up 101 in the Mechanical Arts Sheppard, Mullin, Richter & Hampton LLP
Sep
27
2019
 Nothing Exceptional About Litigation Costs Exceeding Potential Damages McDermott Will & Emery
Sep
27
2019
 Equivalent Disclosure Used To Satisfy Written Description Requirement McDermott Will & Emery
Sep
27
2019
 When Is “Wherein” Clause Limiting? When It’s Material To Patentability McDermott Will & Emery
Sep
27
2019
 Sharp Turnaround On Applicability Of § 112, ¶6 Analysis McDermott Will & Emery
Sep
27
2019
 When is Batting "Lofty"? Look to the Specification McDermott Will & Emery
Sep
27
2019
 No Concrete Controversy if there are No Claims McDermott Will & Emery
Sep
27
2019
 A Decision on Appeal is Final . . . Mostly McDermott Will & Emery
Sep
27
2019
 “Tangential Relation" Exception Saves Patentee's Reliance on DOE McDermott Will & Emery
Sep
25
2019
 After-Final Response Does Not Stop PTA Clock Foley & Lardner LLP
Sep
18
2019
 RCE PTA Carve-Out Resumes After Interference Foley & Lardner LLP
Sep
16
2019
 Perils of Waiting: PTAB’s Precedential Opinion Panel Designates Two More Decisions Rejecting 315(b) Arguments Regarding Time Bars Sheppard, Mullin, Richter & Hampton LLP
Subscribe to Federal Circuit / U.S. Court of Spec. Jurisdiction
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters